ISN Medical’s market expansion drive to bridge diagnoses gap across West African – MD
Felix Ofungwu, the managing director and chief executive officer (CEO) of ISN Medical, says the company’s expansion drive across the West African market will help to bridge gaps in medical diagnoses.
He disclosed that the next phase of growth for ISN Medical would focus on establishing stronger local operations across the region and expanding the company’s consumer healthcare portfolio.
“Our purpose is to play a leading role in the positive transformation of healthcare across Africa,” Ofungwu said.during a recent hybrid press conference in Lagos.
According to him, ISN Medical already has staff in four countries across West and Central Africa and currently serves customers in 21 African countries.
Ofungwu also disclosed that the company is positioning itself for deeper expansion across Africa while also exploring local manufacturing of medical consumables in Nigeria.
He described the healthcare market in Nigeria as one of the most challenging environments to operate in on the back of the country’s low health insurance coverage.
According to him, most Nigerians pay directly for healthcare services, making the sector highly price-sensitive; unlike countries such as Rwanda with high insurance penetration or the United Kingdom with a structured national health system,
“The Nigerian healthcare market is complex. More than 90 percent of patients still pay out-of-pocket for treatment, and that creates pressure on healthcare providers and patients alike,” he said.
On the forthcoming World Health Expo (WHX Lagos 2026), scheduled for June 2-4, Ofungwu said ISN Medical will look to deepen collaboration with other industry experts on strengthening industry wide solutions to Nigeria’s healthcare challenges. “For us to get healthcare right, particularly in Nigeria we have to be collaborative there are challenges we have to find ways to work together to overcome,” he said, reiterating that ISN Medical is not leveraging WHX Lagos to increase sales.
Judith Obi, director, diagnostics, said the company is passionate about innovative solutions in cancer diagnostics and research.
According to her, ISN Medical is not just providing high-end medical equipment and instruments to medical laboratories and hospitals; rather the company support healthcare practitioners to achieve utmost outcome in medical diagnostic solutions.
Ify Chioke, director, consumer health products at ISN Medical, said the company’s mission is to innovate the medical ecosystem in Nigeria for healthcare practitioners and their patients’ peace of mind.
Rodolph Vetchenou, director, Life Sciences, ISN Medical, said artificial intelligence (AI) has become an essential part of modern genomics, particularly in analysing large volumes of genetic data generated through DNA sequencing; a service ISN Medical currently delivers as part of its Life Sciences offering.
He added that the integration of artificial intelligence and genomics into diagnostics and treatment will significantly improve healthcare delivery, reduce medical errors and lower the cost of treatment in Nigeria.
“When you sequence DNA, you generate a lot of data. The only way to make sense of it is by using AI. It helps us compare genomes with reference genomes, identify mutations and understand how those mutations are linked to the clinical condition of patients,” he said.
